Literature DB >> 14600381

Determination of polyacetylenes and ginsenosides in Panax species using high performance liquid chromatography.

Daisuke Washida1, Susumu Kitanaka.   

Abstract

A new HPLC method was developed to separate and identify three polyacetylenes (panaxynol, panaxydol and 1,8-heptadecadiene-4,6-diyne-3,10-diol) found in Panax species. The mobile phase was a linear gradient of 2 : 1 : 3 to 2 : 1 : 1 (v/v/v) methanol/acetonitrile/water in 40 min. HPLC analysis was performed at a flow rate of 1.5 ml/min with UV detection at 254 nm. The contents of the polyacetylenes and ginsenosides in Panax ginseng (white ginseng and red ginseng), P. quinquefolium, P. japonicus, and P. noteginseng were determined using these methods. The species containing the highest polyacetylene content (0.080%) was P. quinquefolium cultivated in Nagano, Japan. Meanwhile, the species with the highest ginsenoside content (9.176%) was P. noteginseng cultivated in Yunnan, China.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600381     DOI: 10.1248/cpb.51.1314

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  17 in total

1.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

2.  Biomass and content of ginsenosides and polyacetylenes in American ginseng roots can be increased without affecting the profile of bioactive compounds.

Authors:  Lars P Christensen; Martin Jensen
Journal:  J Nat Med       Date:  2008-12-16       Impact factor: 2.343

3.  Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway.

Authors:  Jingjing Liu; Guoqing Fan; Ningning Tao; Feifei Feng; Chao Meng; Tieying Sun
Journal:  Drug Des Devel Ther       Date:  2022-06-13       Impact factor: 4.319

4.  Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells.

Authors:  Chong-Zhi Wang; Jing-Tian Xie; Anna Fishbein; Han H Aung; Hui He; Sangeeta R Mehendale; Tong-Chuan He; Wei Du; Chun-Su Yuan
Journal:  Phytother Res       Date:  2009-01       Impact factor: 5.878

5.  Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats.

Authors:  Ye Xiong; Ling Shen; Kristina J Liu; Patrick Tso; Yuqing Xiong; Guangji Wang; Stephen C Woods; Min Liu
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

6.  Ginsenoside Rb1 ameliorates liver fat accumulation by upregulating perilipin expression in adipose tissue of db/db obese mice.

Authors:  Xizhong Yu; Lifang Ye; Hao Zhang; Juan Zhao; Guoqiang Wang; Chao Guo; Wenbin Shang
Journal:  J Ginseng Res       Date:  2014-12-06       Impact factor: 6.060

7.  Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats.

Authors:  Ling Shen; Michael Haas; David Q-H Wang; Aaron May; Chunmin C Lo; Silvana Obici; Patrick Tso; Stephen C Woods; Min Liu
Journal:  Physiol Rep       Date:  2015-09

8.  Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng.

Authors:  Dong-Hyun Kim
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

9.  Ginseng and Its Active Components Ginsenosides Inhibit Adipogenesis in 3T3-L1 Cells by Regulating MMP-2 and MMP-9.

Authors:  Jaeho Oh; Hyunghee Lee; Dongmin Park; Jiwon Ahn; Soon Shik Shin; Michung Yoon
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

10.  Null effect of ginsenoside Rb1 on improving glycemic status in men during a resistance training recovery.

Authors:  Shin-Da Lee; Chia-Hua Kuo; Wei-Hsiang Chang; Ying-Lan Tsai; Chih-Yang Huang; City C Hsieh; Rungchai Chaunchaiyakul; Yu Fang
Journal:  J Int Soc Sports Nutr       Date:  2015-08-20       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.